BDNF receptor antagonism during the induction of morphine dependence exacerbates the severity of physical dependence and ameliorates psychological dependence in rats.

Abstract

This study examined the effects of systemic administration of the TrkB receptor antagonist (ANA-12) during induction of morphine dependence on the severity of physical and psychological dependence and the cerebrospinal fluid (CSF) BDNF levels in morphine-dependent and withdrawn rats. Rats became morphine-dependent by increasing daily doses of morphine for 7 days, along with ANA-12 injection. Then, rats were tested for the severity of physical dependence on morphine (spontaneous withdrawal signs), anxiety-like (the elevated plus maze), depressive-like (sucrose preference test) behaviors after spontaneous morphine withdrawal. Also, the CSF BDNF levels were assessed 2 h after the last dose of morphine and day 13 after morphine withdrawal in morphine-dependent and withdrawn rats. We found that the morphine withdrawal signs were significantly higher in morphine dependent rats receiving ANA-12 on days of 5-7 after morphine withdrawal, also ANA-12 exacerbated overall dependence severity. While, the percentage of time spent in the open arms and sucrose preference were higher in morphine-dependent rats receiving ANA-12 than morphine-dependent rats receiving saline. Also, the ANA-12 injection decreased the CSF BDNF levels following morphine dependence, while increased it after morphine withdrawal. We conclude that the ANA-12 exacerbated the severity of physical morphine dependence but attenuated the anxiety/depressive-like behaviors in morphine-dependent and withdrawn rats. Also, ANA-12 injection was able to reverse the changes in the CSF BDNF levels. Therefore, ANA-12 is not more likely to complete treatment for opiate addiction.

• Authors: Fatemeh Rezamohammadi, Mehrnoush Rahmani, Ali Ghanbari, Ali Khaleghian, Hossein Miladi-Gorji
• Journal: Neuroscience letters (Neurosci Lett) Vol. 737 Pg. 135332 (10 15 2020) ISSN: 1872-7972 [Electronic] Ireland
• PMID: 32860885 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
• Copyright: Copyright © 2020 Elsevier B.V. All rights reserved.

Chemical References

• ANA 12 compound
• Azepines
• Benzamides
• Brain-Derived Neurotrophic Factor
• Receptor, trkB

Topics

• Animals
• Azepines (pharmacology)
• Behavior, Animal (drug effects)
• Benzamides (pharmacology)
• Brain-Derived Neurotrophic Factor (cerebrospinal fluid)
• Dependency, Psychological
• Disease Models, Animal
• Male
• Morphine Dependence (cerebrospinal fluid, diagnosis, metabolism)
• Rats
• Rats, Wistar
• Receptor, trkB (antagonists & inhibitors)
• Severity of Illness Index
• Substance Withdrawal Syndrome (cerebrospinal fluid, metabolism)